FDA: FDA Releases Blueprint to Expand Animal Drug Development for Minor Uses and Minor Species

The Blueprint’s four strategic goals are shaped by input from across the animal health community, including findings from the Reagan-Udall Foundation's Transforming Animal Health in the U.S. for the 21st Century report and the AVMA MUMS Roundtable convened in January 2026.

Read more